Cannabinoid Encyclopedia

Focused research review

DHEA/synaptamide: what the research says

What evidence defines DHEA/synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms?

Updated July 2026 5 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined DHEA/synaptamide. This page brings together 2 research reviews and 3 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about DHEA/synaptamide.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on DHEA/synaptamide covers DHEA/synaptamide biology, receptor or signaling mechanisms, metabolism, physi...; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about DHEA/synaptamide

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

DHEA/synaptamide biology, receptor or signaling mechanisms, metabolism, physi...

This part of the literature focuses on DHEA/synaptamide biology, receptor or signaling mechanisms, metabolism, physi.... Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

Not prominent

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

2 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

3 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on DHEA/synaptamide is not one kind of study. This source set includes 3 animal studies and 2 narrative or expert reviews. 3

The recorded populations or models include animal models (4 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms (5 sources). Closely related outcome names can still describe different measurements. 5

The DHEA/synaptamide source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 1

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development.

On this page, this source examines DHEA / synaptamide and dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms. 1

Study type
narrative or expert review
Population or model
animal models
Outcome focus
dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

animal study

N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling.

On this page, this source examines DHEA / synaptamide and dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms. 2

Study type
animal study
Population or model
animal models
Outcome focus
dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
mechanism-focused research

narrative or expert review

Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function.

On this page, this source examines DHEA / synaptamide and dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms. 3

Study type
narrative or expert review
Outcome focus
dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

animal study

N-Docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation.

On this page, this source examines DHEA / synaptamide and dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms. 4

Study type
animal study
Population or model
animal models
Outcome focus
dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
mechanism-focused research

animal study

Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function.

On this page, this source examines DHEA / synaptamide and dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms. 5

Study type
animal study
Population or model
animal models
Outcome focus
dHEA or synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
mechanism-focused research

Safety and limits

What should readers keep in mind?

Research on DHEA/synaptamide should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence defines DHEA/synaptamide biology, receptor or signaling mechanisms, metabolism, physiology, or safety-relevant mechanisms?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 2

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 3

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 4

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. narrative or expert review; evidence still limited PubMed 21810478 DOI 10.1016/j.prostaglandins.2011.07.002
  2. 2
    N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling. animal study; mechanism-focused research PubMed 27809877 DOI 10.1186/s12974-016-0751-z
  3. 3
    Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function. narrative or expert review; evidence still limited PubMed 22959887 DOI 10.1016/j.plefa.2012.08.002
  4. 4
    N-Docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation. animal study; mechanism-focused research PubMed 23570577 DOI 10.1111/jnc.12255
  5. 5
    Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function. animal study; mechanism-focused research PubMed 27759003 DOI 10.1038/ncomms13123
See all 5 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function. narrative or expert review; evidence still limited / 1 linked research note PubMed 22959887
  2. N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling. animal study; mechanism-focused research / 1 linked research note PubMed 27809877
  3. N-Docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation. animal study; mechanism-focused research / 1 linked research note PubMed 23570577
  4. Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function. animal study; mechanism-focused research / 1 linked research note PubMed 27759003
  5. A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. narrative or expert review; evidence still limited / 1 linked research note PubMed 21810478